Social media guru Gwee joins Chandler Chicco

Share this article:
Shwen Gwee
Shwen Gwee

Social media guru Shwen Gwee has jumped ship from Edelman to Chandler Chicco.

Gwee, who was VP of digital health at Edelman, becomes Chief Digital Officer at Chandler Chicco, where he heads a team of 40, with responsibility for digital strategy across the inVentiv Health subsidiary's shops. He's also part of the network's leadership council and the inVentiv digital and innovation group.

Gwee's is a new position at Chandler Chicco. Ritesh Patel, InVentiv's global head of digital and innovation, was Chandler Chicco's global digital and social lead from 2009 to 2012, but Gwee said his role is "slightly different."

While Monday was officially day one, Gwee has already gotten a start on his long term plans, having met with senior leadership about "what it means to basically take lead of the Chandler Chicco digital practice and drive the digital and social media business.” He said his long-term focus is on “driving innovative product services,” and finding a way for CCC's agencies to put “digital and social in an integrated way into every offering that Chandler Chicco Companies has.”

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Channel


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...